determined by measuring the expression of total Chk1 and pChk1 S345 by western blotting. Lymphoblastoid cell lines (LCLs) were treated 1 hour with Etoposide followed by a 2 hours treatment with the specific pharmacological ATR inhibitor VE-821. Chk1 phosphorylation at S345 was quantified by densitometric analysis. Data are represented as ratio of phosphorylated-to-total. Quantification was performed using the software imageJ 1.49 t. (B) Inhibition of Chk1 was determined by measuring the expression of total Chk1 and pChk1 S296 by western blotting. LCLs were treated 1 hour with Etoposide followed by a 2 hours treatment with the specific pharmacological Chk1 inhibitor CHIR-124. (C) Cell viability was measured by WST-1 assay as described in Materials and Methods. LCLs were exposed to different concentrations of VE-821 or CHIR-124 and cell viability was assessed at different time points.
